Literature DB >> 15088824

Indocyanine green angiography in high myopia.

Ruth Axer-Siegel1, Daniel Cotlear, Ethan Priel, Irit Rosenblatt, Moshe Snir, Dov Weinberger.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate indocyanine green imaging of choroidal changes in pathologic myopia and to compare it with fluorescein angiography. PATIENTS AND METHODS: The angiograms of all consecutive patients with pathologic myopia photographed with confocal indocyanine green angiography using a scanning infrared laser or ophthalmoscope from March 1997 to December 1999 were reviewed.
RESULTS: Twenty-one patients (35 eyes) were included. Indocyanine green angiography was performed in 35 eyes and immediate sequential fluorescein angiography and indocyanine green angiography in 25 eyes. The lacquer cracks were demonstrated to radiate from the disc, at the papillomacular bundle, through the macula, and around the macula. Lacquer cracks were identified in 89% and 28% of the eyes, respectively. Choroidal neovascularization (CNV) was demonstrated in 57% of eyes by indocyanine green angiography and in 56% by fluorescein angiography. All of the CNVs were classic and were located within 300 microm of the foveal center. Seventy percent of the CNVs were delineated in lacquer cracks by indocyanine green angiography. Overall, 124 lacquer cracks were identified by indocyanine green angiography and only 14 by fluorescein angiography. Lipids or serous detachment were not observed. Retinal hemorrhages were noted in 22% and 28% of eyes with indocyanine green angiography and fluorescein angiography, respectively.
CONCLUSION: Confocal indocyanine green angiography offers better delineation of lacquer cracks and the localization of the CNV in lacquer cracks than does fluorescein angiography.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15088824

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  8 in total

Review 1.  Choroidal neovascularisation in pathological myopia: an update in management.

Authors:  W-M Chan; M Ohji; T Y Y Lai; D T L Liu; Y Tano; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

2.  The analysis of lacquer crack in the assessment of myopic choroidal neovascularization.

Authors:  Y M Kim; J U Yoon; H J Koh
Journal:  Eye (Lond)       Date:  2011-04-29       Impact factor: 3.775

3.  Sensitivity of fluorescein angiography alone or with SD-OCT for the diagnosis of myopic choroidal neovascularization.

Authors:  Paolo Milani; Amedeo Massacesi; Marco Setaccioli; Stefania Moschini; Elena Mantovani; Stefano Ciaccia; Fulvio Bergamini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-26       Impact factor: 3.117

4.  Indocyanine green angiographic features of myopic subfoveal choroidal neovascularization as a prognostic factor after photodynamic therapy.

Authors:  Suk Ho Byeon; Oh Woong Kwon; Sung Chul Lee; Sung Soo Kim; Hyoung Jun Koh
Journal:  Korean J Ophthalmol       Date:  2006-03

5.  Choroidal thickness and high myopia: a cross-sectional study and meta-analysis.

Authors:  Shiming Wang; Yong Wang; Xiaoming Gao; Nana Qian; Youer Zhuo
Journal:  BMC Ophthalmol       Date:  2015-07-03       Impact factor: 2.209

6.  Choroidal thickness and biometric markers for the screening of lacquer cracks in patients with high myopia.

Authors:  Nan-Kai Wang; Chi-Chun Lai; Chai Lin Chou; Yen-Po Chen; Lan-Hsin Chuang; An-Ning Chao; Hsiao-Jung Tseng; Chee-Jen Chang; Wei-Chi Wu; Kuan-Jen Chen; Stephen H Tsang
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

Review 7.  Modern Diagnostic Techniques for the Assessment of Ocular Blood Flow in Myopia: Current State of Knowledge.

Authors:  Ewa Grudzińska; Monika Modrzejewska
Journal:  J Ophthalmol       Date:  2018-01-21       Impact factor: 1.909

8.  Long-Term Natural Outcomes of Simple Hemorrhage Associated with Lacquer Crack in High Myopia: A Risk Factor for Myopic CNV?

Authors:  Bing Liu; Xiongze Zhang; Lan Mi; Ling Chen; Feng Wen
Journal:  J Ophthalmol       Date:  2018-01-24       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.